Amgen News

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 4, 2023 19:40 ET

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 8, 2023 14:11 ET

Amgen | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 10, 2023 15:18 ET

Amgen | 424B2: Prospectus

Feb 16, 2023 19:41 ET

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 15, 2023 19:04 ET

Amgen | 424B3: Prospectus

Feb 14, 2023 09:20 ET

Amgen | 424B2: Prospectus

Aug 16, 2022 17:20 ET

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 15, 2022 18:06 ET

Amgen | 424B3: Prospectus

Aug 15, 2022 08:48 ET

Amgen | 424B2: Prospectus

Feb 18, 2022 16:09 ET

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 17, 2022 17:23 ET

Amgen | 424B3: Prospectus

Feb 17, 2022 08:53 ET

Amgen | 424B2: Prospectus

Aug 6, 2021 17:03 ET

Amgen | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Aug 5, 2021 19:28 ET

Amgen | 424B3: Prospectus

Aug 5, 2021 08:31 ET

Amgen | EFFECT: Others

Apr 16, 2021 00:15 ET

Amgen | 424B3: Prospectus

Apr 15, 2021 16:13 ET

Amgen | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Apr 6, 2021 16:02 ET

Amgen | S-4: Registration of securities issued in business combination transactions

Feb 9, 2021 16:45 ET

Amgen | 8-A12B: Registration of a class of securities on a national securities exchange

Dec 28, 2020 16:05 ET